Skip to main content
. 2021 Jul 6;11(7):1221. doi: 10.3390/diagnostics11071221

Figure 6.

Figure 6

Prognostic significance of serum CCT8 and CFL1 in patients with HCC among the Ajou University Hospital liver disease cohort. (a) Expression of serum CCT8 and CFL1 according to BCLC stage guidelines. (Welch’s t-test; * p < 0.05, ** p < 0.01, *** p < 0.001) (b) Expression of serum CCT8 and CFL1 according to presence of vascular invasion. (Welch’s t-test; ** p < 0.01) (c) Overall survival according to expression of serum CCT8 and CFL1 in the validation cohort. (d) Disease-free survival according to expression of serum CCT8 and CFL1 in the validation cohort.